Directory
Portfolio companies.
34,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
3
currently held
Exits tracked
4
hand-checked
Sectors covered
1
across the portfolio
Countries covered
1
from every market
Latest activity
Capital Event · capital-cancellation-shares · Capital structure change
capitalCapital Event · capital-cancellation-shares · Capital structure change
capitalCapital Event · capital-cancellation-shares · Capital structure change
capitalCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway
adminBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board
admin7 companies matching
| Company | Sector | Geo | Investor | Entry | Hold | Status | Buyer | MOIC | |
|---|---|---|---|---|---|---|---|---|---|
Shenghuo Cathay Capital Midcap I | Cathay Capital | 2014 | 6yr | Exited 2020 | China Resources Sanjiu Medical & Pharmaceutical | – | |||
Tianma Tianji Mandarin Capital Partners I | Mindful Capital Partners | 2010 | 5yr | Exited 2015 | – | – | |||
SINDER Cathay Capital Small Cap I | Cathay Capital | 2008 | 6yr | Exited 2014 | – | – | |||
CANbridge General Atlantic | General Atlantic | – | – | Active | – | – | |||
CORXEL Leaps by Bayer | Leaps by Bayer | 2024 | 2yr | Active | – | – | |||
Haihe Pharmaceutical Warburg Pincus Other Investments | Warburg Pincus | – | – | Active | – | – | |||
Shenzhen Salubris Pharmaceutical Co., Ltd Carlyle Sub-Saharan Africa Fund | The Carlyle Group | – | – | Exited | – | – |
Shenghuo
Cathay Capital Midcap I
China
Sector
Pharma
InvestorCathay Capital
Entry
2014
Hold
6yr
Exit
2020
to China Resources Sanjiu Medical & Pharmaceutical
Tianma Tianji
Mandarin Capital Partners I
China
Sector
Pharma
InvestorMindful Capital Partners
Entry
2010
Hold
5yr
Exit
2015
SINDER
Cathay Capital Small Cap I
China
Sector
Pharma
InvestorCathay Capital
Entry
2008
Hold
6yr
Exit
2014
CANbridge
General Atlantic
China
Sector
Pharma
InvestorGeneral Atlantic
Entry
–
CORXEL
Leaps by Bayer
China
Sector
Pharma
InvestorLeaps by Bayer
Entry
2024
Hold
2yr
Haihe Pharmaceutical
Warburg Pincus Other Investments
China
Sector
Pharma
InvestorWarburg Pincus
Entry
–
Shenzhen Salubris Pharmaceutical Co., Ltd
Carlyle Sub-Saharan Africa Fund
China
Sector
Pharma
InvestorThe Carlyle Group
Entry
–